Linda Mary Arterburn

Title: Linda Mary Arterburn: Innovator in Oxylipin Research

Introduction

Linda Mary Arterburn is a prominent inventor based in Ellicott City, MD (US). She has made significant contributions to the field of biochemistry, particularly in the development of novel oxylipins derived from long-chain polyunsaturated fatty acids. With a total of 2 patents, her work has implications for therapeutic and nutritional applications.

Latest Patents

Arterburn's latest patents include innovative methods for producing oxylipins from stearidonic acid and gamma-linolenic acid. These patents disclose novel oxylipins that can be utilized in therapeutic and cosmetic applications, particularly as anti-inflammatory or anti-neurodegenerative compounds. Additionally, her work on oxylipins derived from C22 polyunsaturated fatty acids highlights the potential for these compounds in various health-related applications.

Career Highlights

Linda Mary Arterburn is associated with Martek Biosciences Corporation, where she has been instrumental in advancing research in her field. Her expertise in biochemistry and her innovative approaches have positioned her as a key figure in the development of health-related products.

Collaborations

Throughout her career, Arterburn has collaborated with notable colleagues, including William Robert Barclay and Bindi Dangi. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Linda Mary Arterburn's contributions to the field of oxylipin research demonstrate her commitment to innovation and health. Her patents and collaborative efforts continue to influence therapeutic and nutritional applications, showcasing the importance of her work in the scientific community.